Adjuvant antineoplastics +/- darbepoetin alfa in women with node-positive breast cancer
Phase of Trial: Phase III
Latest Information Update: 01 Jan 2014
At a glance
- Drugs Darbepoetin alfa (Primary) ; Cyclophosphamide; Docetaxel; Doxorubicin; Epirubicin; Fluorouracil
- Indications Early breast cancer
- Focus Therapeutic Use
- Acronyms WSG-ARA Plus
- 01 Jan 2014 Status changed from active, no longer recruiting to completed according to results published in the Annals of Oncology.
- 05 Jan 2012 New trial record
- 10 Dec 2011 Results presented at the 34th Annual San Antonio Breast Cancer Symposium.